![]() |
![]() |
(11) | Number of the document | C 2932970 |
(68) | Number of the document | 2932970 |
(21) | Application number for Supplementary Protection Certificate | PA 2018 013 |
(22) | Date of filing the application | 2018-10-22 |
(41) | Date of publication of the application | 2018-11-12 |
Date of publication of SPC | 2022-04-25 | |
(24) | Date of coming into effect of SPC | 2031-01-25 |
(71) |
VIIV Healthcare Company,
251 Little Falls Drive, Wilmington, DE 19808,
US
|
(73) |
VIIV Healthcare Company,
251 Little Falls Drive, Wilmington, DE 19808,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(93) | EU/1/18/1282/001-002, 2018-05-16 |
(94) | 2033-05-18 |
(95) | Derinys, apimantis dolutegravirą arba farmaciniu požiūriu priimtiną jo druską (pvz., dolutegraviro natrio druską) ir rilpiviriną arba farmaciniu požiūriu priimtiną jo druską (pvz., rilpivirino hidrochloridą) |
SPC revoked (the basic patent revoked after opposition at the EPO) | ||
Date of negative decision to issue the SPC | 2023-12-18 |